Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(CSE: NM )

N/A UNCHANGED
Last Price Updated: 9:49 AM EDT, Jun 13, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.2100 (1,000)
Ask (Size) 0.3800 (2,000)
Prev. Close 0.2950
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies
Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza TORONTO, ON / ACCESSWIRE / December 6, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the... 
From Novamind Inc.
Via AccessWire
Topics Death
Exposures COVID-19 Death

Performance

More News

Read More
Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6
From Novamind Inc.
Via AccessWire
Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network
From Novamind Inc.
Via AccessWire
Novamind Reports Fiscal Q1 Financial Results and Operating Highlights
From Novamind Inc.
Via AccessWire
Novamind Unveils New Logo and Invests in Unified Brand
From Novamind Inc
Via AccessWire
Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona
From Novamind Inc.
Via AccessWire
Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness
From Novamind Ventures Inc.
Via AccessWire
Novamind Enters New Lease Agreement Responding to Patient Demand
From Novamind Inc.
Via AccessWire
Novamind Secures Insurance Coverage for Ketamine from Four Major Payors
From Novamind Inc.
Via AccessWire
Exposures Product Safety
Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading
From Novamind Inc.
Via AccessWire
Novamind Reports FY2021 Financial Results and Operating Highlights
From Novamind Inc.
Via AccessWire
Exposures COVID-19
Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements
From Novamind Inc.
Via AccessWire
Novamind Unveils Stealth Mode Investment in Alto Neuroscience
From Novamind Ventures Inc.
Via AccessWire
Novamind Granted DEA Licenses for Psilocybin Research
From Novamind Inc.
Via AccessWire
Novamind to Present at LD Micro and KCSA Conferences
From Novamind Inc.
Via AccessWire
Novamind Launches New Psychedelic Palliative Care Program
From Novamind Inc.
Via AccessWire
Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021
From Novamind Ventures Inc.
Via AccessWire
Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site
From Novamind Inc.
Via AccessWire
Novamind Announces DTC Eligibility for its Common Shares
From Novamind Inc.
Via AccessWire
Novamind to Present at Benzinga Healthcare Conference
From Novamind Inc.
Via AccessWire
Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF
From Novamind Inc.
Via AccessWire
Novamind to Present at Life Sciences Investor Forum
From Novamind Inc.
Via AccessWire
Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial
From Novamind Inc.
Via AccessWire
Novamind Uplists to OTCQB Venture Market
From Novamind Ventures Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.